What is a veterinary clinical TRIAL?

​A veterinary clinical trial is a scientific investigation conducted to evaluate the safety and efficacy of a drug, treatment, or procedure in animals. 

We have a strong work ethic where integrity and commitment to animal welfare are paramount.
​We ensure that our developments are scientifically sound and contribute to animal well-being.
​Therefore, everything we do is tested multiple times and backed by data. 

What is xep02?

​Xep02 is an innovative therapeutic vaccine developed by Xeptiva Therapeutics, specifically designed for the treatment of canine atopic dermatitis, a chronic condition that causes intense icthing, inflammation, and skin discomfort in dogs. 

Xep02 offers long-lasting action, with the potential to reduce or even eliminate the need for daily medication. 
​

Clinical trial objective

The study aims to evaluate whether Xep02 can become a safe and effective alternative treatment for dogs with atopic dermatitis.

Improving both their health and the caregiving experience of their owners. 


​

what do we know about the efficacy ​
​and security of ​our technology?

Previous studies in dogs have shown that Xep02 vaccine is safe, well-tolerated, and has promising effect in managing chronic allergic skin disease. 

The vaccine has demonstrated the potential to reduce itching and skin inflammation, improve quality of life, and lower the need for long-term use of medicationes like oclacitinib in dogs with moderate to severe atopic dermatitis.

A recen pilot safety trial in dogs confirmed that Xep02 does not produce significant local or systemic side effects, reinforcing its favorable safety profile.

Overall, the available data support the safety and potential efficacy of the Xep02 vaccine as an immunotherapy for dogs living with chronic atopic dermatitits.